Safety Review Evaluates 12hexanediol in Cosmetic Formulations
1,2-Hexanediol, a polyol widely used in cosmetics and personal care products, is valued for its preservative-boosting and moisturizing properties. As toxicological and environmental research expands, the ingredient’s safety profile is drawing closer scrutiny from formulators and researchers. Laboratory and ecological data now point to potential risks at concentration levels relevant to some commercial products.
In vitro tests indicate that 1,2-Hexanediol has measurable biological activity. In a RAW 264.7 macrophage model, cell viability fell below 40% when the concentration reached 0.5%. In kidney-derived HK-2 cells, viability dropped below 10% at 1.0%, with cytotoxicity exceeding 50%.
Because many personal care products on the market contain more than 2% 1,2-Hexanediol, the laboratory results suggest that the ingredient may carry notable cytotoxic risk at certain concentrations. The potential implications for human health warrant attention from product developers.
Beyond cell-level effects, environmental assessment has identified potential phytotoxicity. Experiments showed that the substance inhibited seed germination and root growth in lettuce (L. sativa) and cabbage (B. campestris).
| Test organism | Concentration | Observation |
|---|---|---|
| L. sativa | 0.1% | Complete inhibition of seed germination and root growth |
| B. campestris | 0.1% | Germination observed |
| B. campestris | 1.0%–5.0% | Complete inhibition of germination |
The research indicated that 1,2-Hexanediol can damage plant growth even at a relatively low concentration of 0.1%. When consumer products containing the ingredient enter the environment through domestic wastewater, the potential impact on ecosystems should not be overlooked.
Plant toxicity is not directly equivalent to human toxicity, but it remains a useful indicator in assessing the potential risks of chemicals. Given the cytotoxicity observed for 1,2-Hexanediol, the industry faces higher demands for stability and safety evaluation in formulations. Developers should reassess use concentrations based on available toxicological data and monitor degradation and ecological effects after release into the environment.